Banks and private credit firms are competing to provide at least $5 billion of debt financing to help fund a potential buyout ...

The potential sale of its 88% stake in Bausch + Lomb could generate billions for creditors and shareholders of the indebted ...

Bullish option flow detected in Bausch Health (BHC) with 5,026 calls trading, 2x expected, and implied vol increasing over 2 ...

Bausch Health Companies Inc. ( NYSE:BHC ) shareholders should be happy to see the share price up 26% in the last ...

It was quite a busy and eventful day for the company.

TPG and Blackstone are teaming up to bid for Bausch + Lomb, with an expected valuation between $13 billion and $14 billion.

Bausch Health has recently changed its strategy for Bausch + Lomb, looking to sell the segment which has a market capitalization of nearly $8 billion. The potential sale of Bausch + Lomb is a break ...

Bausch Health faces $21 billion in debt, with $10 billion due by 2027 and a $2.4 billion loan due next year. Private equity ...

Evercore ISI upgraded shares of Bausch + Lomb (NYSE:BLCO – Free Report) from an in-line rating to an outperform rating in a ...

Evercore ISI upgraded shares of Bausch Health Companies (TSE:BHC – Free Report) to a hold rating in a research note published ...

Bausch + Lomb has teamed up with American sportscaster Erin Andrews to promote its dry eye disease treatment, launching the ...